deferiprone has been researched along with Cerebellar Diseases in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Cerebellar Diseases: Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beau-Salinas, F | 1 |
| Guitteny, MA | 1 |
| Donadieu, J | 1 |
| Jonville-Bera, AP | 1 |
| Autret-Leca, E | 1 |
1 other study available for deferiprone and Cerebellar Diseases
| Article | Year |
|---|---|
High doses of deferiprone may be associated with cerebellar syndrome.
Topics: beta-Thalassemia; Cerebellar Diseases; Child; Deferiprone; Female; Humans; Iron Chelating Agents; Ir | 2009 |